Clinical trials
Autism clinical trials
Below are recruiting autism clinical trials, each written for real people, not researchers. We’re tracking 384 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07521371Enrolling by invitation
Intranasal Insulin for Autism in Children and Young Adults
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
Spring, TexasAges 4–21 - NCT04545606Recruiting
Helping kids with autism sleep better by treating insomnia
This study looks for the best way to improve sleep in children with autism who have ongoing insomnia. You and your child will complete sleep tracking and participate in an insomnia treatment plan to reduce trouble falling asleep, staying asleep, or waking too early.
Columbia, MissouriAges 6–12 - NCT07304440RecruitingPhase 1/Phase 2
Stem cell and glutathione therapy study for children with autism
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
Winter Park, FloridaAges 3–12 - NCT06934915RecruitingEarly Phase 1
Prednisone for adults with autism and immune issues
This trial tests if the steroid prednisone can help adults with moderate-to-severe autism who also have signs of immune system problems, like autoimmune disease or inflammation. It might offer a new treatment option for people whose autism is linked to immune activity.
Lexington, MassachusettsAges 18–50 - NCT05699928Recruiting
Testing how well pediatricians spot autism in young children
This study compares an early autism opinion made by a community general pediatrician with a more detailed team assessment. It may help improve how families get autism evaluations sooner and more accurately.
Toronto, OntarioAges birth–5.3 years - NCT06187090Recruiting
Supplement therapy for adults with autism
This trial tests whether a specific supplement can help adults with Level 1 autism. It is open only to Italian-speaking participants aged 18–35 who do not have other major mental health or brain conditions.
Udine, UDAges 18–35 - NCT06872229Recruiting
Sensory integration therapy for attention in autism
This study tests whether sensory integration therapy can help improve attention in children with autism. It looks at how processing senses like touch, sound, and movement might affect focus.
Messina, MEAges 4–12 - NCT07450443RecruitingPhase 2/Phase 3
Gut health and autism: a study on the gut barrier and bacteria
This trial is looking at the connection between the gut and autism. It tests whether certain gut bacteria and the gut's protective barrier are different in children with autism and gastrointestinal issues. This could help find new ways to improve symptoms.
Milan, MIAges 3–8 - NCT07590973Recruiting
Testing a digital app to diagnose autism in children
This study evaluates whether BlinkLab's smartphone app can accurately identify autism in children ages 2–11. Your child would complete short video assessments at home using your phone, and researchers would review the videos to see if the app's results match standard autism testing.
Princeton, New JerseyAges 2–11 - NCT07546942Enrolling by invitationPhase 1/Phase 2
Autism Treatment Using Stem Cells, Gut Microbiome, and Diet
This study tests whether a combination of stem cell therapy, gut microbiome restoration (using specially prepared stool), and dietary changes can improve autism symptoms, communication, social behavior, and digestive issues. Researchers believe gut health and immune system problems may contribute to autism, and this trial explores whether treating these areas helps.
Hamilton, MontanaAges 10–90 - NCT06866275RecruitingPhase 2
Suramin for autism in boys aged 5–14
This trial tests if a medicine called suramin (KZ101) can help with social challenges in boys with autism. It's a 12-week study at one location, and families must be able to visit the site easily.
Orange, CaliforniaAges 5–14 - NCT03583684Recruiting
Brain scan study to predict response to Pivotal Response Treatment
This study uses brain scans to learn which young children with autism are most likely to improve with Pivotal Response Treatment (PRT). It may help families and clinicians choose the best early treatment based on early brain signals.
Stanford, CaliforniaAges 2–4 - NCT03866668RecruitingPhase 2
Esomeprazole for young children with autism
This Phase 2 study tests whether esomeprazole helps children with autism. It looks at children who are generally healthy, take stable medicines, and can reliably attend visits so their care team can track changes during the study.
Stanford, CaliforniaAges 2–6 - NCT04060030RecruitingPhase 2
Leucovorin for young children with autism language difficulties
This Phase 2 study tests whether leucovorin (a vitamin-related medicine) can improve social communication and language in young children with autism. It also looks at safety and whether the results hold while the child stays on their usual therapies and routines.
Phoenix, ArizonaAges 2.5 years–5 years - NCT04107064Recruiting
Job coaching program for autistic adults to work steadily
This study tests a specialized employment program to help autistic adults keep steady work. It may help by improving job readiness and support for working in real workplaces.
Palo Alto, CaliforniaAges 18–55 - NCT04899544Recruiting
Center vs home therapy for autism with PRT coaching
This study compares two ways of delivering Pivotal Response Treatment (PRT) for young children with autism—at a center or in the home. It may help your child by testing which approach better supports language and autism-related communication skills.
Stanford, CaliforniaAges 2–5 - NCT05031364Recruiting
CBT skills coaching for youth with autism and emotional needs
This study tests a therapy program (called CBT) that helps children with autism who also struggle with emotional or behavioral regulation. It aims to reduce emotional outbursts and improve coping while receiving care through community providers.
Culver City, CaliforniaAges 6–14 - NCT05396352Recruiting
Study brain-task skills in autism using brain stimulation
This study looks at how different brain regions work in people with autism and in neurotypical adults using thinking tasks, MRI scans, and a noninvasive brain stimulation called tDCS. It may help researchers better understand social and executive thinking—how you plan and manage tasks.
Washington D.C., District of ColumbiaAges 18–35 - NCT05501678RecruitingPhase 2
Diphenhydramine to help sleep in autistic children
This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.
Stanford, CaliforniaAges 8–17 - NCT05540574RecruitingPhase 2
Zolpidem for sleep problems in autistic children
This Phase 2 study tests zolpidem (a sleep medicine) to help children with autism sleep better. It will check sleep changes using sleep testing and to confirm zolpidem is safe for this age group.
Stanford, CaliforniaAges 8–17 - NCT05546554RecruitingPhase 2
Suvorexant for sleep problems in teens with autism
This Phase 2 study tests whether suvorexant helps improve sleep in children and teens with autism who have significant sleep trouble. It may help reduce behaviors related to poor sleep by changing how the brain promotes sleep.
Stanford, CaliforniaAges 13–17 - NCT05673096Recruiting
PACT therapy for young autistic children and their parents
This trial studies a structured communication therapy program (PACT) for children ages 2–6 who have autism. It aims to improve how children communicate and how families can support communication at home.
AabenraaAges 2–6 - NCT05750095Recruiting
Parenting support program for children with autism
This trial tests parenting programs designed for parents of young children with autism (ages 2–6). It may help you learn practical ways to support your child and your family day to day.
BergenAges 2–6 - NCT05874466Recruiting
Screening app for autism signs in young children
This study tests whether a tablet/computer app can reliably spot early autism signs in toddlers. If it works well, it could help families and clinicians screen sooner and more accurately.
Durham, North CarolinaAges 1.3 years–3 years
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Autism trials by city
Studies with a site in or near these metro areas.
Autism trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for autism?
- Yes. Clin2 currently lists 384 recruiting autism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a autism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a autism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.